High prevalence of p16 staining in malignant tumors
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0262877
Abstract: p16 (CDKN2A) is a member of the INK4 class of cell cycle inhibitors, which is often dysregulated in cancer. However, the prevalence of p16 expression in different cancer types is controversial. 15,783 samples from 124… read more here.
Keywords: cell; p16 staining; p16; prevalence p16 ... See more keywords